Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Development of nanoparticle-based adjuvanted vaccine forthe prevention of Nipah virus infection
Geisbert, T. (PI)
EuBiologics Co Ltd ( Award # )
12/16/25 → 3/31/27
Project: Research project
-
Development of a Marburgvirus subunit vaccine adjuvanted with a novel TLR7/TLR8 agonist
Geisbert, T. (PI)
Abvacc ( Award #5R43AI18129202)
12/1/25 → 1/31/27
Project: Research project
-
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
Geisbert, T. (PI)
AbVacc ( Award #4R44AI17937102)
6/1/25 → 5/31/26
Project: Research project
-
Rapid Ecosystem for Agnostic Antibody DiscoverY (REAADY)
Geisbert, T. (PI)
Vanderbilt University Medical Center ( Award #W911SR2390017)
1/18/25 → 8/17/26
Project: Research project
-
Human Nanobides as Hantavirus Countermeasures
Geisbert, T. (PI)
Henry M. Jackson Foundation for the Advancement of Military Medicine ( Award #HU00012420061)
8/15/24 → 8/14/26
Project: Research project
-
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challenge
Pigeaud, D. D., Borisevich, V., Agans, K. N., Harrison, M. B., O’Toole, R., Martinez, J., Dobias, N. S., Woolsey, C., Fenton, K. A., Geisbert, T. W. & Cross, R. W., Jan 3 2026, In: npj Vaccines. 11, 1, p. 21 21.Research output: Contribution to journal › Article › peer-review
Open Access -
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses
Gaisina, I. N., Argade, M. D., Bott, R., Bradley, S. P., Tomorowicz, Ł., Alvarez, M., Galván Achi, J. M., Cross, R. W., Borisevich, V., O’Toole, R., Amaya, M., Zielinski, C. A., Gaisin, A. M., Nikolic, D., Carlier, P. R., Anantpadma, M., Moore, T. W., Broder, C. C., Geisbert, T. W. & Peet, N. P. & 1 others, , Jan 22 2026, In: Journal of medicinal chemistry. 69, 2, p. 1264-1285 22 p.Research output: Contribution to journal › Article › peer-review
-
Oral 4′-fluorouridine rescues nonhuman primates from advanced Lassa fever
Cross, R. W., Turcinovic, J., Prasad, A. N., Borisevich, V., Agans, K. N., Deer, D. J., O’Toole, R., Dobias, N. S., Woolsey, C., Fenton, K. A. & Geisbert, T. W., Feb 26 2026, In: Nature. 650, 8103, p. 961-969 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Animal Models of Pathogenic New World Arenaviruses
Alvarado, A. V., Cross, R. W., Geisbert, T. W. & Woolsey, C., Jun 2025, In: Microorganisms. 13, 6, 1358.Research output: Contribution to journal › Review article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Ebola virus in Kasai revives 50-year-old questions on viral latency
Bryan, M. E., Nzanzu Vivalya, B. M., Geisbert, T. W., Judson, S. D. & Munster, V., Oct 18 2025, In: The Lancet. 406, 10513, p. 1723 1 p.Research output: Contribution to journal › Letter › peer-review
1 Link opens in a new tab Scopus citations